Cheryl L. Wellington

18.0k total citations · 2 hit papers
174 papers, 11.6k citations indexed

About

Cheryl L. Wellington is a scholar working on Molecular Biology, Neurology and Surgery. According to data from OpenAlex, Cheryl L. Wellington has authored 174 papers receiving a total of 11.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 62 papers in Neurology and 40 papers in Surgery. Recurrent topics in Cheryl L. Wellington's work include Cholesterol and Lipid Metabolism (38 papers), Traumatic Brain Injury and Neurovascular Disturbances (35 papers) and Alzheimer's disease research and treatments (31 papers). Cheryl L. Wellington is often cited by papers focused on Cholesterol and Lipid Metabolism (38 papers), Traumatic Brain Injury and Neurovascular Disturbances (35 papers) and Alzheimer's disease research and treatments (31 papers). Cheryl L. Wellington collaborates with scholars based in Canada, United States and Australia. Cheryl L. Wellington's co-authors include Michael R. Hayden, Blair R. Leavitt, Veronica Hirsch‐Reinshagen, Roshni R. Singaraja, Lynn A. Raymond, Sophie Stukas, Lisa Ellerby, Abigail S. Hackam, Jianjia Fan and Nansheng Chen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Cheryl L. Wellington

168 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cleavage at the Caspase-6 Site Is Required for Neuronal Dysfunction and Degeneration Due to Mutant Huntingtin

2006 505 citations Cheryl L. Wellington, Michael R. Hayden et al. profile →
Vascular contributions to cognitive impairment and dementia including Alzheimer's disease

2014 451 citations Cheryl L. Wellington et al. Alzheimer s & Dementia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheryl L. Wellington Canada	57	6.8k	4.8k	2.5k	2.2k	2.0k	174	11.6k
Kenneth Maiese United States	72	7.3k 1.1×	1.9k 0.4×	761 0.3×	1.1k 0.5×	2.6k 1.3×	220	14.0k
Zhihong Huang China	33	5.6k 0.8×	1.6k 0.3×	1.1k 0.4×	1.0k 0.5×	2.5k 1.3×	135	12.5k
Carsten Culmsee Germany	60	7.0k 1.0×	2.3k 0.5×	1.1k 0.4×	507 0.2×	1.7k 0.9×	162	12.7k
G. William Rebeck United States	62	4.4k 0.7×	2.1k 0.5×	1.7k 0.7×	1.0k 0.5×	6.8k 3.4×	138	11.2k
Robert M. Friedlander United States	59	6.7k 1.0×	5.1k 1.1×	4.0k 1.6×	623 0.3×	1.8k 0.9×	215	14.7k
Hideki Mochizuki Japan	57	3.8k 0.6×	2.9k 0.6×	3.8k 1.5×	546 0.2×	1.8k 0.9×	436	11.4k
Anders Paetau Finland	57	5.1k 0.7×	1.4k 0.3×	3.1k 1.2×	486 0.2×	1.9k 1.0×	223	11.3k
Philip L. Ballard United States	58	3.0k 0.4×	2.0k 0.4×	2.6k 1.0×	2.9k 1.3×	940 0.5×	201	12.5k
Jun Takeda Japan	55	6.2k 0.9×	2.2k 0.5×	632 0.2×	4.4k 2.0×	1.9k 1.0×	310	13.1k
Markus Schwaninger Germany	60	4.1k 0.6×	1.7k 0.4×	1.1k 0.4×	659 0.3×	1.8k 0.9×	217	12.3k

Countries citing papers authored by Cheryl L. Wellington

Since Specialization

Citations

This map shows the geographic impact of Cheryl L. Wellington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Wellington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Wellington more than expected).

Fields of papers citing papers by Cheryl L. Wellington

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Wellington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Wellington. The network helps show where Cheryl L. Wellington may publish in the future.

Co-authorship network of co-authors of Cheryl L. Wellington

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Wellington. A scholar is included among the top collaborators of Cheryl L. Wellington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Wellington. Cheryl L. Wellington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muir, Ryan T., Sophie Stukas, Andrew E. Beaudin, et al.. (2025). Plasma biomarkers distinguish Boston Criteria 2.0 cerebral amyloid angiopathy from healthy controls. Alzheimer s & Dementia. 21(3). e70010–e70010. 1 indexed citations

Su, Wayne, Johnson Chen, Vesna Sossi, et al.. (2024). Differences in brain structure and cognitive performance between patients with long-COVID and those with normal recovery. NeuroImage. 300. 120859–120859. 4 indexed citations

Padgett, Christine, Karen Mason, Cheryl L. Wellington, et al.. (2024). Detecting a hidden pandemic: The current state and future direction of screening and assessment tools for intimate partner violence-related brain injury. Neuroscience & Biobehavioral Reviews. 167. 105912–105912. 2 indexed citations

Criado‐Marrero, Marangelie, Sakthivel Ravi, Lakiesha N. Williams, et al.. (2024). Age dictates brain functional connectivity and axonal integrity following repetitive mild traumatic brain injuries in mice. NeuroImage. 298. 120764–120764. 4 indexed citations

Cheng, Wai Hang, et al.. (2024). Age at Injury as a Modifier of Preclinical TBI Behavioral, Neuropathological, and Inflammatory Outcomes. Advances in neurobiology. 42. 263–283. 1 indexed citations

Cooper, Jennifer, Jean‐Michel Galarneau, Douglas D. Fraser, et al.. (2023). Characterizing Factors Influencing Baseline Plasma Biomarkers for Sport-Related Concussion in Adolescents. Journal of Neurotrauma. 40(15-16). 1638–1650. 6 indexed citations

Wellington, Cheryl L., et al.. (2023). Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia. Molecular Neurodegeneration. 18(1). 86–86. 16 indexed citations

Cheng, Wai Hang, Emily B. Button, Asma Bashir, et al.. (2020). ApoA-I deficiency has a subtle effect on acute inflammatory responses after experimental Traumatic Brain Injury. Open Collections. 6(1). 1 indexed citations

Hoiland, Ryan L., Sophie Stukas, Jennifer Cooper, et al.. (2020). Amelioration of COVID‐19‐related cytokine storm syndrome: parallels to chimeric antigen receptor‐T cell cytokine release syndrome. British Journal of Haematology. 190(3). e150–e154. 28 indexed citations

10.

Liu, Jiangui, et al.. (2019). Technique and preliminary findings for in vivo quantification of brain motion during injurious head impacts. Journal of Biomechanics. 95. 109279–109279. 9 indexed citations

11.

Fan, Jianjia, Wenchen Zhao, Yoko Shimizu, et al.. (2016). Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes. PLoS ONE. 11(9). e0162384–e0162384. 18 indexed citations

12.

Stukas, Sophie, et al.. (2011). The LXR agonist GW3965 increases apoA-I protein levels in the central nervous system independent of ABCA1. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1821(3). 536–546. 19 indexed citations

13.

Takechi, Ryusuke, Susan Galloway, Menuka M. Pallebage‐Gamarallage, et al.. (2009). Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-β. British Journal Of Nutrition. 103(5). 652–662. 64 indexed citations

14.

Burgess, Braydon L., Margaret M. Racke, Veronica Hirsch‐Reinshagen, et al.. (2008). ABCG1 influences the brain cholesterol biosynthetic pathway but does not affect amyloid precursor protein or apolipoprotein E metabolism in vivo. Journal of Lipid Research. 49(6). 1254–1267. 52 indexed citations

15.

Wahrle, Suzanne E., Hong Jiang, Maia Parsadanian, et al.. (2008). Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. Journal of Clinical Investigation. 118(2). 671–82. 311 indexed citations

16.

Tansley, Gavin, Braydon L. Burgess, Su Yuan, et al.. (2007). The cholesterol transporter ABCG1 modulates the subcellular distribution and proteolytic processing of β-amyloid precursor protein. Journal of Lipid Research. 48(5). 1022–1034. 46 indexed citations

17.

Abildayeva, Karlygash, Paula J. Jansen, Veronica Hirsch‐Reinshagen, et al.. (2006). 24(S)-Hydroxycholesterol Participates in a Liver X Receptor-controlled Pathway in Astrocytes That Regulates Apolipoprotein E-mediated Cholesterol Efflux. Journal of Biological Chemistry. 281(18). 12799–12808. 200 indexed citations

18.

Wellington, Cheryl L.. (2004). Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Clinical Genetics. 66(1). 1–16. 48 indexed citations

19.

Nucifora, Frederick C., Lisa Ellerby, Cheryl L. Wellington, et al.. (2003). Nuclear Localization of a Non-caspase Truncation Product of Atrophin-1, with an Expanded Polyglutamine Repeat, Increases Cellular Toxicity. Journal of Biological Chemistry. 278(15). 13047–13055. 68 indexed citations

20.

Holbert, Sébastien, Adam Rosenblatt, Cheryl L. Wellington, et al.. (2001). The Gln-Ala repeat transcriptional activator CA150 interacts with huntingtin: Neuropathologic and genetic evidence for a role in Huntington's disease pathogenesis. Proceedings of the National Academy of Sciences. 98(4). 1811–1816. 143 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact